Clincosm LogoSign in Get a demo

male breast cancer

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast - Female, Male Breast Cancer Trial in Charlotte (Pembrolizumab, Paclitaxel)

Completed
Has Results
  • Breast - Female
  • Male Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 25, 2023

Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)

Completed
  • Male Breast Cancer
  • +7 more
  • propranolol hydrochloride
  • Correlative Studies
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 4, 2022

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Male Breast Cancer Trial in Groningen (AndroGel)

Not yet recruiting
  • Male Breast Cancer
  • Groningen, Netherlands
    UMCG
May 17, 2022

Finasteride and Male Breast Cancer - A Register-Based Nested

Completed
  • Male Breast Cancer
    • (no location specified)
    Feb 7, 2022

    Treating Patients With Stage IV Breast Cancer

    Active, not recruiting
    • Central Nervous System Metastases
    • +15 more
    • hyperfractionated radiation therapy
    • +2 more
    • North Chicago, Illinois
      University of Chicago
    Dec 6, 2021

    Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

    Completed
    Has Results
    • Adult Solid Tumor
    • +38 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Feb 18, 2021

    Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (tipifarnib, paclitaxel, doxorubicin)

    Completed
    Has Results
    • Breast Cancer
    • +5 more
    • Tampa, Florida
    • +6 more
    Jan 29, 2021

    HER2-positive Breast Cancer, Male Breast Cancer, Stage IIIB Breast Cancer Trial in Seattle (biological, procedure, other)

    Completed
    • HER2-positive Breast Cancer
    • +4 more
    • HER-2/neu intracellular domain protein
    • +5 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Feb 7, 2020

    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

    Completed
    • HER2-positive Breast Cancer
    • +7 more
    • HER-2/neu peptide vaccine
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Feb 4, 2020

    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, procedure, radiation, other)

    Completed
    Has Results
    • Male Breast Cancer
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Jan 2, 2020

    CNS Metastases, HER2-positive Breast Cancer, Male Breast Cancer Trial in Los Angeles (lapatinib ditosylate, everolimus,

    Completed
    • Central Nervous System Metastases
    • +4 more
    • lapatinib ditosylate
    • +3 more
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Nov 8, 2019

    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Duarte, South Pasadena (vorinostat, ixabepilone,

    Completed
    • Male Breast Cancer
    • +2 more
    • Duarte, California
    • +1 more
    Nov 1, 2019

    Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Male Breast Cancer Trial in Winston-Salem (omega-3 fatty

    Completed
    Has Results
    • Ductal Breast Carcinoma in Situ
    • +8 more
    • omega-3 fatty acid
    • +2 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Oct 7, 2019

    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Seattle (drug, other, procedure, radiation,

    Completed
    Has Results
    • Male Breast Cancer
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Aug 15, 2019

    Inflammatory Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in United States (drug, biological, procedure,

    Completed
    Has Results
    • Inflammatory Breast Cancer
    • +5 more
    • sunitinib malate
    • +7 more
    • Anchorage, Alaska
    • +6 more
    Jul 23, 2019

    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer Trial in Chicago (eribulin mesylate,

    Unknown status
    • Estrogen Receptor-negative Breast Cancer
    • +10 more
    • eribulin mesylate
    • +2 more
    • Chicago, Illinois
      Northwestern University
    Jun 6, 2019

    Male Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Houston (biological, drug, procedure, other)

    Terminated
    Has Results
    • Male Breast Cancer
    • +4 more
    • oblimersen sodium
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 8, 2019

    Cancer of the Breast, Breast Cancer, Advanced Breast Cancer Trial in United States (Seviteronel)

    Completed
    • Cancer of the Breast
    • +6 more
    • Birmingham, Alabama
    • +35 more
    Jan 31, 2019

    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

    Completed
    Has Results
    • Male Breast Cancer
    • +5 more
    • ONTAK
    • +5 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    Nov 9, 2018

    HER2-positive Breast Cancer, Male Breast Cancer, Stage II Breast Cancer Trial in Rochester (HER-2/neu peptide vaccine,

    Completed
    • HER2-positive Breast Cancer
    • +5 more
    • HER-2/neu peptide vaccine
    • laboratory biomarker analysis
    • Rochester, Minnesota
      Mayo Clinic
    Oct 4, 2018

    Male Breast Cancer Trial in Essen (Tamoxifen, Tamoxifen and GnRH analogue, Exemestane and GnRH analogue)

    Completed
    • Male Breast Cancer
    • Essen, Nordrhein-Westfalen, Germany
      Kliniken Essen-Mitte
    Sep 18, 2018

    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Chicago, Evanston (mifepristone, ,

    Completed
    • Male Breast Cancer
    • +5 more
    • Chicago, Illinois
    • +1 more
    Sep 10, 2018

    Male Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer Trial in Chicago, Evanston (mifepristone,

    Completed
    • Male Breast Cancer
    • +7 more
    • Chicago, Illinois
    • +1 more
    Sep 10, 2018

    Estrogen Receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer Trial

    Terminated
    Has Results
    • Estrogen Receptor-positive Breast Cancer
    • +6 more
    • Tucson, Arizona
      Arizona Cancer Center
    Jul 23, 2018